Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Non-Current Assets (2019 - 2026)

Immatics (IMTX) posted Non-Current Assets of $67.9 million for Q4 2025, down 4.06% sequentially from $70.8 million in Q3 2025, and down 4.58% YoY from $71.2 million in Q4 2024.

Analysis

Immatics (IMTX) Non-Current Assets (2019 - 2026) Analysis & Trends

Immatics has reported Non-Current Assets for 7 years, with the latest figure at $67.9 million in Q4 2025.

  • Quarterly Non-Current Assets fell 4.58% year-over-year to $67.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $67.9 million (down 4.58% YoY) and the FY2025 annual result came in at $65.9 million, down 8.57% from the prior year.
  • Non-Current Assets eased to $67.9 million in Q4 2025 per IMTX's latest filing, from $70.8 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $73.1 million in Q2 2024 and troughed at $19.0 million in Q1 2021.
  • A 5-year average of $49.3 million and a median of $53.4 million in 2023 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2023 and 2025: Non-Current Assets soared 108.38% in 2023, then declined 4.58% in 2025.
  • Over 5 years, Non-Current Assets stood at $25.7 million in 2021, then grew by 21.88% to $31.3 million in 2022, then jumped by 108.38% to $65.2 million in 2023, then increased by 9.15% to $71.2 million in 2024, then dropped by 4.58% to $67.9 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $67.9 million, $70.8 million, and $71.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.15 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 294.93 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.96 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 938.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 18.06 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 468.65 Mn
10 Immatics 1.17 Bn 711.21 Mn - 65.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65.72 Mn
Mar 31, 2026 68.40 Mn
Dec 31, 2025 67.90 Mn
Sep 30, 2025 70.77 Mn
Jun 30, 2025 71.73 Mn
Mar 31, 2025 71.66 Mn
Dec 31, 2024 71.16 Mn
Sep 30, 2024 70.79 Mn
Jun 30, 2024 73.07 Mn
Mar 31, 2024 70.32 Mn
Dec 31, 2023 65.20 Mn
Sep 30, 2023 57.09 Mn
Jun 30, 2023 49.62 Mn
Mar 31, 2023 35.89 Mn
Dec 31, 2022 31.29 Mn
Sep 30, 2022 32.25 Mn
Jun 30, 2022 34.44 Mn
Mar 31, 2022 24.99 Mn
Dec 31, 2021 25.67 Mn
Sep 30, 2021 22.14 Mn